Literature DB >> 24003062

Retraction: The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab.

Roman Perez-Soler, Yiyu Zou, Tianhong Li, Yi-He Ling.   

Abstract

Entities:  

Year:  2013        PMID： 24003062     DOI： 10.1158/1078-0432.CCR-13-1912

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  1 in total

1.  Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.

Authors:  Jesper Grau Eriksen; Inger Kaalund; Ole Clemmensen; Jens Overgaard; Per Pfeiffer
Journal:  Support Care Cancer       Date:  2017-02-15       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.